| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neurocrine Biosciences, Inc. (NBIX) has 17 insiders with recent SEC Form 4 filings, including 1 buy and 35 sells. NBIX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 140.4K | $22.74M | - | |
| Other | 52.8K | $8.54M | - | |
| Other | 46.8K | $7.57M | - | |
| Other | 39.6K | $6.42M | -36,937 | |
| Other | 36.8K | $5.97M | -22,000 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 24, 2023 | Roberts Eiry49 | Chief Medical Officer | Sell | 14,400 | $103.48 | $1,490,058.72 | -35.1% | -3.4% | +35.3% | |
| Apr 21, 2023 | Rastetter William H48 | Director | Sale+OE | 6,937 | $105.03 | $728,605.23 | -8.6% | -6.0% | +26.7% | |
| Feb 23, 2023 | Neurocrine Biosciences Inc | 10% Owner | Buy | 4,395,588 | $8.88 | $39,032,821.44 | +105.2% | -9.1% | +31.7% | |
| Feb 8, 2023 | Lippoldt Darin60 | Chief Legal Officer | Sell | 16,275 | $102.71 | $1,671,636.70 | -9.6% | -6.9% | +28.6% | |
| Feb 8, 2023 | Gorman Kevin Charles55 | Chief Executive Officer | Sell | 29,044 | $102.90 | $2,988,757.87 | -1.5% | -6.9% | +28.6% | |
| Feb 8, 2023 | Gano Kyle54 | Chief Business Development Off | Sell | 17,004 | $102.79 | $1,747,919.93 | -3.4% | -6.9% | +28.6% | |
| Feb 8, 2023 | Boyer David W.51 | Chief Corp. Affairs Officer | Sell | 25,238 | $102.49 | $2,586,741.39 | -46.8% | -6.9% | +28.6% | |
| Feb 8, 2023 | Abernethy Matt57 | Chief Financial Officer | Sell | 28,588 | $102.61 | $2,933,469.99 | -17.8% | -6.9% | +28.6% | |
| Feb 8, 2023 | Benevich Eric62 | Chief Commercial Officer | Sell | 19,650 | $102.70 | $2,018,104.78 | -15.7% | -6.9% | +28.6% | |
| Feb 8, 2023 | Cooke Julie59 | Chief Human Resources Officer | Sell | 17,079 | $102.76 | $1,755,121.31 | -9.6% | -6.9% | +28.6% |